Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine augmentation of single-session exposure therapy for spider or dog phobia in children
ACTRN12610000490077Phase 4Recruiting
- Sponsor
- Macquarie University
- Start
- Aug 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in specific phobia comparing Exposure therapy + d-cycloserine with Exposure therapy + placebo (2 arms). Primary endpoints: Behavioral Avoidance Test performance and Fear during therapist-assisted exposure treatment. Started Aug 2010; status: recruiting.
02
Drugs
d-cycloserine
03
Conditions
specific phobia
Beyond the preview
Go deeper on ACTRN12610000490077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000490077.